Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine Switch in Early-Stage Psychosis
NCT01968161Phase 4Unknown
- Sponsor
- CERVO Brain Research Centre
- Start
- Oct 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of asenapine in schizophrenia, psychotic disorder, sponsored by CERVO Brain Research Centre. Status: unknown.
02
Drugs
asenapine
03
Conditions
schizophreniapsychotic disorder
Beyond the preview
Go deeper on NCT01968161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01968161.